财务摘要（报告期）（Cellectar Biosciences Inc）
| 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|
| 每股指标： | ||||||||
| 每股收益EPS基本(元) | -3.11 | -2.71 | -1.49 | -0.76 | -4.05 | -3.50 | -2.22 | -0.10 |
| 每股净资产(元) | -0.07 | 0.46 | -0.05 | 0.75 | 1.65 | 2.09 | 0.33 | 0.45 |
| 每股经营现金净流量(元) | -1.56 | -2.30 | -1.51 | -0.74 | -2.69 | -2.91 | -0.18 | -0.08 |
| 每股现金流量净额(元) | -0.50 | -0.09 | -1.51 | -0.74 | -1.69 | -2.93 | -0.18 | -0.08 |
| 盈利能力： | ||||||||
| 净资产收益率平均(%) | -536.81 | -304.21 | -223.43 | -75.14 | -117.82 | -93.40 | -51.00 | -20.38 |
| 总资产净利率(%) | -225.65 | -141.56 | -119.60 | -47.11 | -97.30 | -75.67 | -43.03 | -17.75 |
| 投入资本回报率ROIC(%) | -1,794.20 | -1,424.28 | -1,091.20 | -442.42 | -1,775.78 | -1,410.69 | -1,050.41 | -430.27 |
| 收益质量： | ||||||||
| 营业利润／利润总额(%) | 102.41 | 86.50 | 101.17 | 101.45 | 100.53 | 100.02 | 100.01 | 100.01 |
| 资本结构： | ||||||||
| 资产负债率(%) | 111.23 | 78.81 | 107.17 | 50.57 | 28.17 | 34.00 | 22.01 | 14.95 |
| 权益乘数 | -8.90 | 4.72 | -13.94 | 2.02 | 1.39 | 1.52 | 1.28 | 1.18 |
| 产权比率 | -9.90 | 3.72 | -14.94 | 1.02 | 0.39 | 0.52 | 0.28 | 0.18 |
| 流动资产／总资产(%) | 86.56 | 93.31 | 86.18 | 93.31 | 95.09 | 97.11 | 97.66 | 98.14 |
| 非流动资产／总资产(%) | 13.44 | 6.69 | 13.82 | 6.69 | 4.91 | 2.89 | 2.34 | 1.86 |
| 流动负债／负债合计(%) | 96.32 | 96.98 | 92.39 | 92.69 | 90.91 | 99.18 | 98.38 | 97.29 |
| 非流动负债／负债合计(%) | 3.68 | 3.02 | 7.61 | 7.31 | 9.09 | 0.82 | 1.62 | 2.71 |
| 归属母公司股东的权益／投入资本(%) | -54.01 | 178.10 | -34.43 | 340.23 | 899.80 | 831.09 | 1,858.07 | 2,006.48 |
| 偿债能力： | ||||||||
| 流动比率 | 0.81 | 1.22 | 0.87 | 1.99 | 3.71 | 2.88 | 4.51 | 6.75 |
| 速动比率 | 0.81 | 1.22 | 0.87 | 1.99 | 3.71 | 2.88 | 4.51 | 6.75 |
| 货币资金／流动负债(%) | 73.93 | 115.27 | 79.95 | 182.34 | 359.29 | 272.98 | 442.47 | 658.61 |
| 营业利润／流动负债(%) | -301.14 | -160.36 | -263.75 | -125.15 | -521.11 | -328.33 | -242.16 | -132.01 |
| 经营活动产生的现金流量净额／流动负债(%) | -250.25 | -138.31 | -228.28 | -103.28 | -456.16 | -273.37 | -192.60 | -108.35 |
| 归属母公司股东的权益／负债合计(%) | -10.10 | 26.89 | -6.69 | 97.74 | 254.96 | 194.10 | 354.39 | 569.11 |
| 经营活动产生的现金流量净额／负债合计(%) | -241.05 | -134.14 | -210.91 | -95.73 | -414.69 | -271.13 | -189.48 | -105.41 |
| 营业利润／负债合计(%) | -290.07 | -155.52 | -243.68 | -116.01 | -473.73 | -325.64 | -238.24 | -128.43 |
| 成长能力： | ||||||||
| 总资产同比增长率(%) | -44.07 | 11.55 | -74.86 | -53.62 | -41.97 | -53.95 | -45.76 | -41.90 |
| 每股净资产同比增长率(%) | -103.96 | -77.93 | -114.51 | 69.09 | 205.52 | 230.45 | -58.47 | -52.83 |
| 总负债同比增长率(%) | 120.83 | 158.54 | 22.42 | 56.95 | 46.33 | 95.05 | 51.77 | -9.60 |
| 基本每股收益同比增长率(%) | 23.21 | 22.57 | 32.88 | 24.00 | 6.90 | -3.24 | 9.39 | 23.08 |
| 归属母公司股东的权益同比增长率(%) | -108.74 | -64.18 | -102.31 | -73.04 | -53.07 | -66.96 | -54.09 | -45.34 |
| 营业利润同比增长率(%) | -35.22 | -23.47 | -25.22 | -41.77 | -19.40 | -17.48 | -9.59 | 3.45 |
| 股东权益合计同比增长率(%) | -108.74 | -64.18 | -102.31 | -73.04 | -53.07 | -66.96 | -54.09 | -45.34 |
| 营运能力： | ||||||||
| 衍生指标： | ||||||||
| 现金及现金等价物净增加额TTM(元) | -10,301,370.00 | 1,201,121.00 | -19,652,593.00 | -17,951,431.00 | -15,837,617.00 | -22,559,405.00 | -21,972,290.00 | -22,992,600.00 |
| 利润总额TTM(元) | -38,043,496.00 | -37,809,931.00 | -31,888,903.00 | -31,102,724.00 | -28,661,254.00 | -27,304,260.00 | -25,312,002.00 | -23,904,989.00 |
| 投入资本(元) | 2,510,592.00 | 2,564,322.00 | 1,356,193.00 | 2,155,765.00 | 1,723,432.00 | 1,534,191.00 | 1,086,831.00 | 1,356,064.00 |
| 经营活动产生的现金流量净额TTM(元) | -32,376,974.00 | -30,193,037.00 | -29,138,329.00 | -27,366,188.00 | -25,222,301.00 | -22,321,550.00 | -21,737,438.00 | -22,856,042.00 |
| 归属母公司净利润TTM(元) | -37,983,496.00 | -37,749,931.00 | -31,828,903.00 | -31,042,724.00 | -28,601,254.00 | -27,304,260.00 | -25,312,002.00 | -23,904,989.00 |
| 所得税TTM(元) | -60,000.00 | -60,000.00 | -60,000.00 | -60,000.00 | -60,000.00 | - | - | - |